MP
Highly rated in
8
conditions
Highly rated in
8
conditions

About Dr. Massimo Primignani

Massimo Primignani is in Milan, Italy. Dr. Primignani is highly rated in 8 conditions, according to our data. His top areas of expertise are Esophageal Varices, Budd-Chiari Syndrome, Portal Hypertension, and Mesenteric Venous Thrombosis.

His clinical research consists of co-authoring 81 peer reviewed articles in the past 15 years.

Locations
  Milan, IT
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


81 Total Publications

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published —June 08, 2021
Thrombopoietin receptor agonists before elective invasive procedures in cirrhotic patients with thrombocytopenia: ready to start?


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
University Of Milan
 
Milan, IT 
 0.1 km
Maria Cappellini-Domenica is in Milan, Italy. They have been an author on 351 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Fondazione IRCCS Istituto Nazionale Dei Tumori
 
Milan, IT 
 0.1 km
Silvia Stacchiotti is in Milan, Italy. They have been an author on 187 peer reviewed articles and participated in 21 clinical trials in the past 15 years.
Highly rated in
0
conditions
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
 
Milan, IT 
 0.1 km
Wilma Barcellini is in Milan, Italy. They have been an author on 130 peer reviewed articles and participated in 1 clinical trial in the past 15 years.